Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors

Anna‐Maria Monforte; Angela Rao; Patrizia Logoteta; Stefania Ferro; Laura De Luca; Maria Letizia Barreca; Nunzio Iraci; Giovanni Maga; De Clercq Erik; Christophe Pannecouque; Alba Chimirri

doi:10.1016/j.bmc.2008.06.012

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2010

Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

Anna‐Maria Monforte, Patrizia Logoteta, Laura De Luca, Nunzio Iraci, Stefania Ferro, Giovanni Maga, De Clercq Erik, Christophe Pannecouque, Alba Chimirri

Article2004

2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors

Angela Rao, Jan Balzarini, Anna Carbone, Alba Chimirri, De Clercq Erik, Anna‐Maria Monforte, Pierre Monforte, Christophe Pannecouque, Maria Zappalà

Article2008

Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

Yueping Wang, Fen‐Er Chen, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Article2022

Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailability

Limin Zhao, Shuai Wang, Christophe Pannecouque, De Clercq Erik, Hu‐Ri Piao, Fen‐Er Chen

Article2011

Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

Jing Zhang, Peng Zhan, Jingde Wu, Zhenyu Li, Yan Jiang, Weiying Ge, Christophe Pannecouque, De Clercq Erik, Xinyong Liu